Contact Us
Quotes News NAV
Market Watch
02 Apr EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
 
Market Info EXPAND TICKER
You are here : Equity   |  News   |  Corporate Results
Your Result on : Equity   |  News | Corporate Results | Detailed News
Profit or loss trends for various companies
Back
Vivimed Labs reports consolidated net loss of Rs 16.55 crore in the December 2025 quarter
14-Mar-26   07:35 Hrs IST

Net Loss of Vivimed Labs reported to Rs 16.55 crore in the quarter ended December 2025 as against net loss of Rs 5.98 crore during the previous quarter ended December 2024. Sales declined 56.20% to Rs 15.99 crore in the quarter ended December 2025 as against Rs 36.51 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales15.9936.51 -56
OPM %-68.292.88 -
PBDT-11.930.64 PL
PBT-16.55-5.98 -177
NP-16.55-5.98 -177

Powered by Capital Market - Live News
Pre-Session
Mid-Session
End-Session
Quick Review
Hot Pursuit
Stock Alert
Economy News
Corporate News
Foreign Markets
Corporate Results
Futures Market
Other Markets
Political News
Mutual Fund News
IPO News
Market Commentary
Site Map | Disclaimer | Circular Reports | Research Reports | About Us | Feedback | Careers | Contact Us
Useful Links
Stock : Stock Price Quotes | Stock Market India | Stock Market Global | Corporate Announcement
Market News : Corporate News | Market Commentary | Corporate Results | Economy News | Other Markets | Hot Pursuit | Futures Market
Share Market Updates : BSE Top Gainers - Sensex | NSE Top Gainers - Nifty | BSE Top Losers - Sensex | NSE Top Losers - Nifty | BSE Most Active Scrip by Volume - Sensex |
NSE Most Active Scrip by Volume - Nifty | BSE Most Active Scrip by Value - Sensex | NSE Most Active Scrip by Value - Nifty | Advances and Declinces
Derivatives : Get Quotes | Daily Settlement Prices | Put-Call Ratio | Cost Of Carry
Global Indicator : Stock Market Global | Currency | ADR Prices | FII Investments | Mutual Fund Investments
Services : Equity | Derivatives | Commodities | Mutual Fund | Portfolio Management Services (PMS) | Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints : investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)